Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

odiparcil

Known as: 4-Methyl-7-(5-Thio-beta-D-Xylopyranosyloxy)-2H-Chromen-2-One 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2020
2020
Mucopolysaccharidoses are a class of lysosomal storage diseases, characterized by enzymatic deficiency in the degradation of… Expand
  • figure 1
  • figure 2
  • figure 3
  • table 1
  • figure 4
Is this relevant?
2019
2019
Anticoagulant drugs comprise a specific subcategory of antithrombotic agents that act to inhibit blood coagulation at various… Expand
Is this relevant?
2014
2014
2014
 
Is this relevant?
2013
Review
2012
Review
2012
Current anticoagulant provision is dominated by parenteral heparin and oral warfarin, which act by inhibiting several steps of… Expand
  • figure 1
  • table I
  • table II
  • figure 2
  • table III
Is this relevant?
2008
2008
Odiparcil is a novel, orally active β‐d‐thioxyloside analog with antithrombotic activity associated with a reduced risk of… Expand
Is this relevant?
2006
2006
Summary  Background: A significant need exists for new chronic oral anticoagulation therapies to replace warfarin. Previous… Expand
Is this relevant?
Review
2006
Review
2006
Current anticoagulant provision is dominated by parenteral heparin and oral warfarin, which act by inhibiting several steps of… Expand
Is this relevant?